Bellicum Pharma (BLCM) Misses Q2 EPS by 4c
Tweet
Share
E-mailGet Alerts BLCM Hot Sheet
Join SI Premium – FREE
Bellicum Pharma (NASDAQ: BLCM) reported Q2 EPS of ($0.61), $0.04 worse than the analyst estimate of ($0.57).
For earnings history and earnings-related data on Bellicum Pharma (BLCM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
- ThinkEquity Starts Deep Isolation Nuclear (DBHL) at Buy
- Morgan Stanley Starts Target Hospitality (TH) at Overweight
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
